Patent ID: 11419841

Abstract:
The present invention relates to compound of formula (I): wherein  R is O—R3 or  R1 and R2 are identical or different and are each independently H, (C1-C6)alkyl, —CO—(C1-C21)alkyl or —CO—(C11-C21)alkenyl group, provided that at least one of R1 or R2 is H or (C1-C6)alkyl,  R3 is a —CO—(C11-C21)alkyl or —CO—(C11-C21)alkenyl group,  or its pharmaceutically acceptable salts, racemates, diastereoisomers, enantiomers, or mixtures thereof,  for use in prevention and/or treatment of a disease or disorder linked to an exacerbated vascular, lymphatic or mucosal permeability.